Literature DB >> 2976082

Peripheral blood lymphocyte phenotype and function in multiple sclerosis.

P J Hughes1, D A Compston.   

Abstract

T suppressor cell function and phenotype are abnormal in patients with multiple sclerosis, especially during the chronic progressive phase but the sub-populations defined by mitogen stimulation and serological methods may not be identical. In this study, involving 45 patients with multiple sclerosis and 33 controls, there was no correlation between T suppressor function and CD8 cell phenotype in patients with multiple sclerosis or in controls. These phenotypic and functional studies cannot therefore be used interchangeably in the assessment of patients with multiple sclerosis since they provide different information about lymphocyte subpopulations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2976082      PMCID: PMC1033024          DOI: 10.1136/jnnp.51.9.1187

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activity.

Authors:  C F Scott; L E Spitler
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

2.  Suppressor T cells are activated in vivo in patients with multiple sclerosis coinciding with remission from acute attack.

Authors:  J R Huddlestone; M B Oldstone
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

3.  Abnormal regulation of in vitro IgG production in multiple sclerosis.

Authors:  R E Kelly; G W Ellison; L W Myers; V Goymerac; S B Larrick; C C Kelley
Journal:  Ann Neurol       Date:  1981-03       Impact factor: 10.422

4.  Azathioprine decreases suppressor T cells in patients with multiple sclerosis.

Authors:  J L Trotter; G E Rodey; H M Gebel
Journal:  N Engl J Med       Date:  1982-02-11       Impact factor: 91.245

5.  Altered regulation of mitogen responsiveness by suppressor cells in multiple sclerosis.

Authors:  R L Gonzalez; P C Dau; L E Spitler
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

6.  Abnormal regulation of IgG production in multiple sclerosis.

Authors:  J M Goust; E L Hogan; P Arnaud
Journal:  Neurology       Date:  1982-03       Impact factor: 9.910

7.  Influence of azathioprine (imuran) on in vitro immune function in multiple sclerosis.

Authors:  J J Oger; J P Antel; H H Kuo; B G Arnason
Journal:  Ann Neurol       Date:  1982-02       Impact factor: 10.422

8.  Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.

Authors:  S Haahr; A Møller-Larsen; E Pedersen
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

9.  Suppressor cell activity in multiple sclerosis.

Authors:  W C Wallen; S A Houff; M Iivanainen; V P Calabrese; G H DeVries
Journal:  Neurology       Date:  1981-06       Impact factor: 9.910

10.  Suppressor T cells in family members of patients with multiple sclerosis.

Authors:  P J Hughes; P F Kirk; D A Compston
Journal:  Brain       Date:  1986-10       Impact factor: 13.501

View more
  2 in total

1.  Dual labelling of circulating CD8 cells in patients with multiple sclerosis.

Authors:  P J Hughes; P F Kirk; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

2.  Prolonged dynamic clinico-immunological observation of 85 patients with definite multiple sclerosis: first steps towards monitoring process activity.

Authors:  E I Gusev; T L Demina; A N Boiko; B V Pinegin
Journal:  J Neurol       Date:  1994-07       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.